Ningxia: Filling the gap in the study of the treatment of alcoholic liver injury in China

　　Medicine Network December 10th, December 9th, by Bai Ruiyuan and the Chinese Academy of Sciences Su Guohui academician team of the research project "the treatment mechanism of erythropoietin to alcohol liver injury" results in Ningxia Yinchuan successfully passed the Ningxia Science and Technology Department identification, this scientific research results to fill a gap in the domestic redery on the treatment of alcohol liver injury "Study on the Treatment Mechanism of Alcohol-alcohol Liver Injury" marks the latest progress in the study of the main ingredient of fentanyorin in Ningxia, and provides new clues for the study of the mechanism of the main ingredients of the main ingredient serotto in Ningxia After the evaluation, the evaluation team experts agreed that the treatment mechanism of erythropoietin for alcoholic liver injury research results reached the leading domestic level it is understood that since 2015, Su Guohui academician and his team and Bai Ruiyuan jointly carried out the "Research on the Treatment Mechanism of alcohol-based liver injury" project, Su Guohui academician for the first time put forward the "redery" this "new term." Erytosin (zeaxanthin dipalmate) is a fat-soluble polyisoprene compound that contains a large number of conjugate dicoste, which can play a protective role in antioxidant and anti-inflammatory The research shows that a large amount of carotenoids have accumulated in the ripe fruits of Ningxia, especially the content of erythropoietin is the most abundant in Ningxia red fruit, accounting for 56% to 75% of the total amount of pigmented substances In the mouse alcoholic liver injury model, erythropoietin can improve inflammatory damage to the liver by directly binding and regulating the liver's anti-alcohol intake caused by P2X7 receptor and lipophilin receptor antagonist alcohol intake on the liver cell membrane, restore the mitochondrial autophagy function inhibited by alcohol, inhibit the activation of the inflammatory small body of NLRP3, thereby improving the inflammatory damage in the liver , , said: "The current research on the role of monomer health care is less, the attention gained in the world is not enough, I hope this cooperation can promote erythropoietin in the future to become a major topic in the field of Chinese medicine research." Zhang Jinhong, head of technology at BairuiYuan, said: "Research on the treatment mechanism of erythropoietin for alcohol-related liver injury will bring new production capacity to the development of Ningxia's radon industry and lead the industry towards a deeper field of processing." "
"The study of the treatment mechanism of erythropoietin for alcoholic liver injury" successfully passed the identification of the results, entered the process route design, opened the application of the transformation of the results, in order to explore the components of radon in human effect plays an important role The deep development and precision research of Ningxia province has taken a big step forward, and opened up a new space for Ningxia's industry, which will lead the further high-quality development of Ningxia's industry (Complete)